{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T07:03:23Z","timestamp":1776755003197,"version":"3.51.2"},"reference-count":212,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.cellimm.2022.104554","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T11:32:38Z","timestamp":1653564758000},"page":"104554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["T-cell evasion and invasion during HIV-1 infection: The role of HIV-1 Tat protein"],"prefix":"10.1016","volume":"377","author":[{"given":"Mahmoud","family":"Mohammad Yaseen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nizar","family":"Mohammad Abuharfeil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Homa","family":"Darmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cellimm.2022.104554_b0005","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00005-014-0293-y","article-title":"Heterogeneity in the differentiation and function of CD8(+) T cells","volume":"62","author":"Mittrucker","year":"2014","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.cellimm.2022.104554_b0010","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3389\/fimmu.2019.00618","article-title":"Dual role of CD4 in peripheral T lymphocytes","volume":"10","author":"Glatzova","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104554_b0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/cyto.a.22348","article-title":"T helper cells plasticity in inflammation","volume":"85","author":"Cosmi","year":"2014","journal-title":"Cytometry A."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104554_b0020","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.intimp.2015.03.050","article-title":"Molecular control of CD4(+) T cell lineage plasticity and integrity","volume":"28","author":"Ellmeier","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellimm.2022.104554_b0025","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2022.104554_b0030","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1146\/annurev-immunol-042617-053411","article-title":"CD4 helper and CD8 cytotoxic T cell differentiation","volume":"36","author":"Taniuchi","year":"2018","journal-title":"Annu. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.cellimm.2022.104554_b0035","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200111","article-title":"Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine","volume":"10","author":"Yaseen","year":"2020","journal-title":"Open Biol."},{"key":"10.1016\/j.cellimm.2022.104554_b0040","article-title":"Recent advances in myeloid-derived suppressor cell biology","author":"Yaseen","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.cellimm.2022.104554_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104440","article-title":"The impact of MDSCs on the efficacy of preventive and therapeutic HIV vaccines","volume":"369","author":"Yaseen","year":"2021","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2022.104554_b0050","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3389\/fimmu.2019.01719","article-title":"T Cell Dysfunction in Cancer Immunity and Immunotherapy","volume":"10","author":"Xia","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2022.104554_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.600829","article-title":"Biomechanics of T cell dysfunctions in chronic diseases","volume":"12","author":"Gunasinghe","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104554_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hivar.2015.07.004","article-title":"HIV-1 strategies to overcome the immune system by evading and invading innate immune system","volume":"15","author":"Alqudah","year":"2016","journal-title":"HIV & AIDS Review."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104554_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00705-017-3569-9","article-title":"The role of polymorphonuclear neutrophils during HIV-1 infection","volume":"163","author":"Yaseen","year":"2018","journal-title":"Arch. Virol."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104554_b0070","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1021\/acsinfecdis.8b00167","article-title":"Harnessing antibody-dependent cellular cytotoxicity to control HIV-1 infection","volume":"5","author":"Abuharfeil","year":"2019","journal-title":"ACS Infect. Dis."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104554_b0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/08830185.2016.1225301","article-title":"Broadly neutralizing antibodies: an approach to control HIV-1 infection","volume":"36","author":"Yaseen","year":"2017","journal-title":"Int. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.cellimm.2022.104554_b0080","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1089\/vim.2017.0065","article-title":"Mechanisms and factors that drive extensive human immunodeficiency virus type-1 hypervariability: an overview","volume":"30","author":"Yaseen","year":"2017","journal-title":"Viral Immunol."},{"key":"10.1016\/j.cellimm.2022.104554_b0085","doi-asserted-by":"crossref","DOI":"10.1089\/vim.2021.0115","article-title":"Anatomical distribution of myeloid-derived suppressor cells during HIV infection","author":"Yaseen","year":"2021","journal-title":"Viral Immunol."},{"key":"10.1016\/j.cellimm.2022.104554_b0090","article-title":"MDSCs and the pathogenesis of HIV infection","author":"Yaseen","year":"2021","journal-title":"Open Biol."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104554_b0095","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1182\/blood-2003-04-1203","article-title":"Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy","volume":"103","author":"Harari","year":"2004","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.cellimm.2022.104554_b0100","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/nm1482","article-title":"Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction","volume":"12","author":"Trautmann","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2022.104554_b0105","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3389\/fimmu.2018.00616","article-title":"Elevated level of CD4(+) T cell immune activation in acutely HIV-1-infected stage associates with increased IL-2 production and cycling expression, and subsequent CD4(+) T cell preservation","volume":"9","author":"Xia","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2022.104554_b0110","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1128\/JVI.02228-07","article-title":"Chronic CD4+ T-cell activation and depletion in human immunodeficiency virus type 1 infection: type I interferon-mediated disruption of T-cell dynamics","volume":"82","author":"Sedaghat","year":"2008","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104554_b0115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/imr.12066","article-title":"CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure","volume":"254","author":"Okoye","year":"2013","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.cellimm.2022.104554_b0120","doi-asserted-by":"crossref","DOI":"10.1172\/JCI138861","article-title":"NLRP3 inflammasome induces CD4+ T cell loss in chronically HIV-1-infected patients","volume":"131","author":"Zhang","year":"2021","journal-title":"J Clin Invest."},{"key":"10.1016\/j.cellimm.2022.104554_b0125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ebiom.2015.12.004","article-title":"Small CD4 mimetics prevent HIV-1 uninfected bystander CD4 + T cell killing mediated by antibody-dependent cell-mediated cytotoxicity","volume":"3","author":"Richard","year":"2016","journal-title":"EBioMedicine."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104554_b0130","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/ejh.13350","article-title":"HIV-1 inhibits haematopoiesis via microRNA secreted by virus-infected CD4+ T cells","volume":"104","author":"Padmanabhan","year":"2020","journal-title":"Eur. J. Haematol."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104554_b0135","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01344-18","article-title":"Bone marrow-derived CD4(+) T cells are depleted in simian immunodeficiency virus-infected macaques and contribute to THE Size of the replication-competent reservoir","volume":"93","author":"Hoang","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.cellimm.2022.104554_b0140","doi-asserted-by":"crossref","first-page":"13864","DOI":"10.1038\/srep13864","article-title":"Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice","volume":"5","author":"Fiume","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104554_b0145","doi-asserted-by":"crossref","first-page":"7748","DOI":"10.1038\/s41598-017-07570-5","article-title":"Chronic low-level expression of HIV-1 Tat promotes a neurodegenerative phenotype with aging","volume":"7","author":"Dickens","year":"2017","journal-title":"Sci. Rep."},{"issue":"6531","key":"10.1016\/j.cellimm.2022.104554_b0150","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/375497a0","article-title":"Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120","volume":"375","author":"Westendorp","year":"1995","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.cellimm.2022.104554_b0155","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/nm0996-960","article-title":"HIV-1 Tat protein as a potential AIDS vaccine","volume":"2","author":"Goldstein","year":"1996","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.cellimm.2022.104554_b0160","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nm1296-1371","article-title":"The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1\/KDR receptor on vascular endothelial cells","volume":"2","author":"Albini","year":"1996","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.cellimm.2022.104554_b0165","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1128\/jvi.64.6.2519-2529.1990","article-title":"Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1","volume":"64","author":"Schwartz","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.cellimm.2022.104554_b0170","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.virol.2018.03.006","article-title":"Tat controls transcriptional persistence of unintegrated HIV genome in primary human macrophages","volume":"518","author":"Meltzer","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.cellimm.2022.104554_b0175","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fcimb.2020.00061","article-title":"HIV-1 Tat: Role in Bystander Toxicity","volume":"10","author":"Ajasin","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.cellimm.2022.104554_b0180","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3389\/fmicb.2015.01164","article-title":"The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders","volume":"6","author":"Mediouni","year":"2015","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104554_b0185","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1389450116666150531162212","article-title":"HIV-1 tat-mediated calcium dysregulation and neuronal dysfunction in vulnerable brain regions","volume":"17","author":"Hu","year":"2016","journal-title":"Curr. Drug Targets"},{"issue":"3","key":"10.1016\/j.cellimm.2022.104554_b0190","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s13365-019-00737-y","article-title":"HIV-associated neurodegeneration: exploitation of the neuronal cytoskeleton","volume":"25","author":"Wenzel","year":"2019","journal-title":"J Neurovirol."},{"key":"10.1016\/j.cellimm.2022.104554_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104701","article-title":"Signatures of HIV-1 subtype B and C Tat proteins and their effects in the neuropathogenesis of HIV-associated neurocognitive impairments","volume":"136","author":"Williams","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"24","key":"10.1016\/j.cellimm.2022.104554_b0200","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1007\/s00018-020-03561-4","article-title":"Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND","volume":"77","author":"Marino","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"issue":"16","key":"10.1016\/j.cellimm.2022.104554_b0205","doi-asserted-by":"crossref","first-page":"27569","DOI":"10.18632\/oncotarget.15174","article-title":"Tat is a multifunctional viral protein that modulates cellular gene expression and functions","volume":"8","author":"Clark","year":"2017","journal-title":"Oncotarget."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104554_b0210","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-0854.2011.01286.x","article-title":"The ins and outs of HIV-1 Tat","volume":"13","author":"Debaisieux","year":"2012","journal-title":"Traffic."},{"issue":"10","key":"10.1016\/j.cellimm.2022.104554_b0215","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1093\/nar\/gkq037","article-title":"Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon","volume":"38","author":"Lopez-Huertas","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.cellimm.2022.104554_b0220","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/15216540310001643440","article-title":"The HIV-1 Tat transactivator protein: a therapeutic target?","volume":"55","author":"Fulcher","year":"2003","journal-title":"IUBMB Life"},{"key":"10.1016\/j.cellimm.2022.104554_b0225","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1742-4690-6-50","article-title":"What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?","volume":"6","author":"Campbell","year":"2009","journal-title":"Retrovirology."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104554_b0230","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2031","article-title":"Tat basic domain: A \u201cSwiss army knife\u201d of HIV-1 Tat?","volume":"29","author":"Kurnaeva","year":"2019","journal-title":"Rev. Med. Virol."},{"issue":"10","key":"10.1016\/j.cellimm.2022.104554_b0235","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1002\/j.1460-2075.1988.tb03181.x","article-title":"Functional domains required for tat-induced transcriptional activation of the HIV-1 long terminal repeat","volume":"7","author":"Garcia","year":"1988","journal-title":"EMBO J."},{"issue":"8","key":"10.1016\/j.cellimm.2022.104554_b0240","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1101\/gad.4.8.1365","article-title":"A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation","volume":"4","author":"Roy","year":"1990","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104554_b0245","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0092-8674(81)90020-9","article-title":"RNA recognition by Tat-derived peptides: Interaction in the major groove?","volume":"66","author":"Weeks","year":"1991","journal-title":"Cell"},{"issue":"22","key":"10.1016\/j.cellimm.2022.104554_b0250","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1101\/gad.12.22.3512","article-title":"The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein","volume":"12","author":"Garber","year":"1998","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104554_b0255","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1128\/jvi.63.3.1181-1187.1989","article-title":"Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein","volume":"63","author":"Hauber","year":"1989","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104554_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/jvi.63.1.1-8.1989","article-title":"Structural and functional characterization of human immunodeficiency virus tat protein","volume":"63","author":"Ruben","year":"1989","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.cellimm.2022.104554_b0265","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0962-8924(00)01771-2","article-title":"Protein transduction: unrestricted delivery into all cells?","volume":"10","author":"Schwarze","year":"2000","journal-title":"Trends Cell Biol."},{"issue":"4","key":"10.1016\/j.cellimm.2022.104554_b0270","doi-asserted-by":"crossref","DOI":"10.3390\/v12040471","article-title":"Role of divalent cations in HIV-1 replication and pathogenicity","volume":"12","author":"Khan","year":"2020","journal-title":"Viruses."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104554_b0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1208\/s12248-008-9071-2","article-title":"Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment","volume":"11","author":"El-Sayed","year":"2009","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104554_b0280","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/1389450116666150825110658","article-title":"HIV-1 tat and immune dysregulation in aids pathogenesis: a therapeutic target","volume":"17","author":"Chiozzini","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.cellimm.2022.104554_b0285","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/123605","article-title":"Impact of tat genetic variation on HIV-1 disease","volume":"2012","author":"Li","year":"2012","journal-title":"Adv Virol."},{"issue":"6 Pt 1","key":"10.1016\/j.cellimm.2022.104554_b0290","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/BF02256316","article-title":"Requirement for the second coding exon of Tat in the optimal replication of macrophage-tropic HIV-1","volume":"10","author":"Neuveut","year":"2003","journal-title":"J. Biomed. Sci."},{"issue":"17","key":"10.1016\/j.cellimm.2022.104554_b0295","doi-asserted-by":"crossref","first-page":"7941","DOI":"10.1073\/pnas.90.17.7941","article-title":"The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence","volume":"90","author":"Barillari","year":"1993","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"6","key":"10.1016\/j.cellimm.2022.104554_b0300","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/emboj\/16.6.1224","article-title":"Tat is required for efficient HIV-1 reverse transcription","volume":"16","author":"Harrich","year":"1997","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.cellimm.2022.104554_b0305","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2174\/157016207781662443","article-title":"The HIV-1 Tat protein stimulates reverse transcription in vitro","volume":"5","author":"Apolloni","year":"2007","journal-title":"Curr. HIV Res."},{"issue":"9","key":"10.1016\/j.cellimm.2022.104554_b0310","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1128\/JVI.03440-14","article-title":"A mutant tat protein inhibits HIV-1 reverse transcription by targeting the reverse transcription complex","volume":"89","author":"Lin","year":"2015","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.cellimm.2022.104554_b0315","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1128\/JVI.75.6.2675-2683.2001","article-title":"Role for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication","volume":"75","author":"Kameoka","year":"2001","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104554_b0320","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/nar\/gkt934","article-title":"Dynamic interactions of the HIV-1 Tat with nucleic acids are critical for Tat activity in reverse transcription","volume":"42","author":"Boudier","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.cellimm.2022.104554_b0325","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/emboj.2010.32","article-title":"Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells","volume":"29","author":"Rayne","year":"2010","journal-title":"EMBO J."},{"issue":"21","key":"10.1016\/j.cellimm.2022.104554_b0330","doi-asserted-by":"crossref","first-page":"11466","DOI":"10.1073\/pnas.97.21.11466","article-title":"Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1","volume":"97","author":"Xiao","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"33","key":"10.1016\/j.cellimm.2022.104554_b0335","doi-asserted-by":"crossref","first-page":"13588","DOI":"10.1073\/pnas.1308673110","article-title":"Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein","volume":"110","author":"Johnson","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 2","key":"10.1016\/j.cellimm.2022.104554_b0340","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1097\/QAD.0000000000002268","article-title":"Presence of Tat and transactivation response element in spinal fluid despite antiretroviral therapy","volume":"33","author":"Henderson","year":"2019","journal-title":"AIDS."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104554_b0345","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/187152612798994939","article-title":"Antiretroviral therapy does not block the secretion of the human immunodeficiency virus tat protein","volume":"12","author":"Mediouni","year":"2012","journal-title":"Infect. Disord. Drug Targets"},{"issue":"3","key":"10.1016\/j.cellimm.2022.104554_b0350","article-title":"Anti-tat immunity in HIV-1 infection: effects of naturally occurring and vaccine-induced antibodies against tat on the course of the disease","volume":"7","author":"Cafaro","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.cellimm.2022.104554_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103306","article-title":"Anti-tat immunity defines CD4(+) T-cell dynamics in people living with HIV on long-term cART","volume":"66","author":"Tripiciano","year":"2021","journal-title":"EBioMedicine."},{"issue":"4","key":"10.1016\/j.cellimm.2022.104554_b0360","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23040933","article-title":"HIV Tat\/P-TEFb interaction: a potential target for novel anti-HIV therapies","volume":"23","author":"Asamitsu","year":"2018","journal-title":"Molecules"},{"issue":"28","key":"10.1016\/j.cellimm.2022.104554_b0365","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.2174\/1381612823666170704130635","article-title":"The HIV-1 tat protein: mechanism of action and target for HIV-1 cure strategies","volume":"23","author":"Rice","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"11","key":"10.1016\/j.cellimm.2022.104554_b0370","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1007\/s00705-021-05158-z","article-title":"New insights into pathogenesis point to HIV-1 Tat as a key vaccine target","volume":"166","author":"Ensoli","year":"2021","journal-title":"Arch. Virol."},{"issue":"5","key":"10.1016\/j.cellimm.2022.104554_b0375","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2022.104554_b0380","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clim.2016.08.012","article-title":"Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease","volume":"171","author":"Ye","year":"2016","journal-title":"Clin Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104554_b0385","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10549-017-4281-x","article-title":"Elevated T cell activation score is associated with improved survival of breast cancer","volume":"164","author":"Lu","year":"2017","journal-title":"Breast Can. Res. Treat."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104554_b0390","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12967-019-02160-7","article-title":"The prognostic role of circulating CD8(+) T cell proliferation in patients with untreated extensive stage small cell lung cancer","volume":"17","author":"An","year":"2019","journal-title":"J Transl Med."},{"key":"10.1016\/j.cellimm.2022.104554_b0395","doi-asserted-by":"crossref","first-page":"3201940","DOI":"10.1155\/2018\/3201940","article-title":"The progress of T cell immunity related to prognosis in gastric cancer","volume":"2018","author":"Wei","year":"2018","journal-title":"Biomed Res. Int."},{"issue":"17","key":"10.1016\/j.cellimm.2022.104554_b0400","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1158\/1078-0432.CCR-19-0389","article-title":"Cytotoxic T cells and their activation status are independent prognostic markers in meningiomas","volume":"25","author":"Rapp","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.cellimm.2022.104554_b0405","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/hiv.12470","article-title":"MicroRNA-155 is a biomarker of T-cell activation and immune dysfunction in HIV-1-infected patients","volume":"18","author":"Jin","year":"2017","journal-title":"HIV Med."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104554_b0410","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2249.1993.tb08182.x","article-title":"T cell activation and disease severity in HIV infection","volume":"93","author":"Mahalingam","year":"1993","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.cellimm.2022.104554_b0415","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/374786","article-title":"T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy","volume":"187","author":"Hunt","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"7109","key":"10.1016\/j.cellimm.2022.104554_b0420","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.cellimm.2022.104554_b0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077746","article-title":"The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses","volume":"8","author":"Nicoli","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellimm.2022.104554_b0430","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.3389\/fimmu.2018.02569","article-title":"T-cell exhaustion in chronic infections: reversing the state of exhaustion and reinvigorating optimal protective immune responses","volume":"9","author":"Saeidi","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2022.104554_b0435","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-2567.2010.03255.x","article-title":"T-cell exhaustion: characteristics, causes and conversion","volume":"129","author":"Yi","year":"2010","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.cellimm.2022.104554_b0440","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/imr.12079","article-title":"HIV-associated chronic immune activation","volume":"254","author":"Paiardini","year":"2013","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.cellimm.2022.104554_b0445","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1182\/blood-2003-09-3333","article-title":"Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load","volume":"104","author":"Deeks","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cellimm.2022.104554_b0450","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1086\/524143","article-title":"Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy","volume":"197","author":"Hunt","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.cellimm.2022.104554_b0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004955","article-title":"HIV latency is established directly and early in both resting and activated primary CD4 T cells","volume":"11","author":"Chavez","year":"2015","journal-title":"PLoS Pathog."},{"issue":"21","key":"10.1016\/j.cellimm.2022.104554_b0460","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01194-19","article-title":"Activation of latent HIV-1 T cell reservoirs with a combination of innate immune and epigenetic regulators","volume":"93","author":"Palermo","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.cellimm.2022.104554_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102853","article-title":"A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infection","volume":"59","author":"Mann","year":"2020","journal-title":"EBioMedicine."},{"issue":"12","key":"10.1016\/j.cellimm.2022.104554_b0470","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1038\/nprot.2014.188","article-title":"A primary CD4(+) T cell model of HIV-1 latency established after activation through the T cell receptor and subsequent return to quiescence","volume":"9","author":"Kim","year":"2014","journal-title":"Nat. Protoc."},{"issue":"5","key":"10.1016\/j.cellimm.2022.104554_b0475","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/QAD.0000000000000594","article-title":"Low SAMHD1 expression following T-cell activation and proliferation renders CD4+ T cells susceptible to HIV-1","volume":"29","author":"Ruffin","year":"2015","journal-title":"AIDS."},{"key":"10.1016\/j.cellimm.2022.104554_b0480","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1186\/s12879-014-0683-0","article-title":"The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study","volume":"14","author":"Meijerink","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cellimm.2022.104554_b0485","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev.pharmtox.48.121806.154841","article-title":"Chemokines and their receptors: drug targets in immunity and inflammation","volume":"48","author":"Viola","year":"2008","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104554_b0490","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41467-022-28130-0","article-title":"Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry","volume":"13","author":"Claireaux","year":"2022","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.cellimm.2022.104554_b0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002818","article-title":"Directly infected resting CD4+T cells can produce HIV Gag without spreading infection in a model of HIV latency","volume":"8","author":"Pace","year":"2012","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104554_b0500","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/COH.0000000000000241","article-title":"HIV infection and immune activation: the role of coinfections","volume":"11","author":"Boulougoura","year":"2016","journal-title":"Curr Opin HIV AIDS."},{"key":"10.1016\/j.cellimm.2022.104554_b0505","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.663843","article-title":"Residual viremia is linked to a specific immune activation profile in HIV-1-infected adults under efficient antiretroviral therapy","volume":"12","author":"Younas","year":"2021","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.cellimm.2022.104554_b0510","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/infdis\/jir667","article-title":"Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy","volume":"204","author":"Dahl","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"23","key":"10.1016\/j.cellimm.2022.104554_b0515","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.1128\/JVI.05607-11","article-title":"Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infection","volume":"85","author":"Haas","year":"2011","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.cellimm.2022.104554_b0520","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002840","article-title":"CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction","volume":"8","author":"Peretz","year":"2012","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.cellimm.2022.104554_b0525","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.4049\/jimmunol.1002000","article-title":"CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7","volume":"186","author":"Catalfamo","year":"2011","journal-title":"J. Immunol."},{"issue":"26","key":"10.1016\/j.cellimm.2022.104554_b0530","doi-asserted-by":"crossref","first-page":"14620","DOI":"10.1073\/pnas.011512398","article-title":"Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication","volume":"97","author":"Secchiero","year":"2000","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"11","key":"10.1016\/j.cellimm.2022.104554_b0535","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.it.2006.09.006","article-title":"Bystander T cell activation\u2013implications for HIV infection and other diseases","volume":"27","author":"Bangs","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cellimm.2022.104554_b0540","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.0105-2896.2006.00382.x","article-title":"Signals required for programming effector and memory development by CD8+ T cells","volume":"211","author":"Mescher","year":"2006","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104554_b0545","doi-asserted-by":"crossref","DOI":"10.15406\/moji.2014.01.00011","article-title":"Costimulation of effector CD8+ T Cells: which receptor is optimal for immunotherapy?","volume":"1","author":"Barber","year":"2014","journal-title":"MOJ Immunology."},{"issue":"9","key":"10.1016\/j.cellimm.2022.104554_b0550","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.4049\/jimmunol.164.9.4465","article-title":"The roles of CD28 and CD40 ligand in T cell activation and tolerance","volume":"164","author":"Howland","year":"2000","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.cellimm.2022.104554_b0555","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/intimm\/10.8.1083","article-title":"CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells","volume":"10","author":"Johnson-Leger","year":"1998","journal-title":"Int. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104554_b0560","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.coi.2010.02.013","article-title":"Inflammatory cytokines as a third signal for T cell activation","volume":"22","author":"Curtsinger","year":"2010","journal-title":"Curr. Opin. Immunol."},{"issue":"9","key":"10.1016\/j.cellimm.2022.104554_b0565","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1084\/jem.20021910","article-title":"Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function","volume":"197","author":"Curtsinger","year":"2003","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104554_b0570","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.cellimm.2022.104554_b0575","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/QAD.0000000000001734","article-title":"The HIV-1 Tat protein affects human CD4+ T-cell programing and activation, and favors the differentiation of naive CD4+ T cells","volume":"32","author":"Nicoli","year":"2018","journal-title":"AIDS."},{"issue":"5","key":"10.1016\/j.cellimm.2022.104554_b0580","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.4049\/jimmunol.0711406","article-title":"HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection","volume":"182","author":"Fanales-Belasio","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104554_b0585","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4049\/jimmunol.168.1.197","article-title":"Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses","volume":"168","author":"Fanales-Belasio","year":"2002","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cellimm.2022.104554_b0590","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.4049\/jimmunol.173.6.3838","article-title":"HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity","volume":"173","author":"Gavioli","year":"2004","journal-title":"J. Immunol."},{"issue":"25","key":"10.1016\/j.cellimm.2022.104554_b0595","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/sj.gt.3302115","article-title":"The cationic region from HIV tat enhances the cell-surface expression of epitope\/MHC class I complexes","volume":"10","author":"Leifert","year":"2003","journal-title":"Gene Ther."},{"issue":"5","key":"10.1016\/j.cellimm.2022.104554_b0600","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.vaccine.2007.11.040","article-title":"The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: implications for the design of new vaccination strategies against AIDS","volume":"26","author":"Gavioli","year":"2008","journal-title":"Vaccine."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104554_b0605","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bbrc.2005.02.042","article-title":"HIV-1 Tat modulates T-bet expression and induces Th1 type of immune response","volume":"329","author":"Kulkarni","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"15","key":"10.1016\/j.cellimm.2022.104554_b0610","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1097\/00002030-200110190-00005","article-title":"CCR5 and CXCR4 expression correlated with X4 and R5 HIV-1 infection yet not sustained replication in Th1 and Th2 cells","volume":"15","author":"Moonis","year":"2001","journal-title":"AIDS."},{"issue":"16","key":"10.1016\/j.cellimm.2022.104554_b0615","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1097\/QAD.0000000000001630","article-title":"Preferential susceptibility of Th9 and Th2 CD4+ T cells to X4-tropic HIV-1 infection","volume":"31","author":"Orlova-Fink","year":"2017","journal-title":"AIDS."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104554_b0620","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jcv.2014.04.004","article-title":"Prevalence of R5 and X4 HIV variants in antiretroviral treatment experienced patients with virologic failure","volume":"60","author":"Ferrer","year":"2014","journal-title":"J. Clin. Virol."},{"issue":"10","key":"10.1016\/j.cellimm.2022.104554_b0625","doi-asserted-by":"crossref","first-page":"e875","DOI":"10.1016\/j.ijid.2013.02.020","article-title":"Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infection","volume":"17","author":"Bon","year":"2013","journal-title":"Int J Infect Dis."},{"issue":"8","key":"10.1016\/j.cellimm.2022.104554_b0630","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/jmv.20900","article-title":"Prevalence of X4 tropic HIV-1 variants in patients with differences in disease stage and exposure to antiretroviral therapy","volume":"79","author":"Poveda","year":"2007","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cellimm.2022.104554_b0635","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1471-2334-13-220","article-title":"X4 viruses are frequently archived in patients with long-term HIV infection but do not seem to influence the \u201cinflamm-aging\u201d process","volume":"13","author":"Saracino","year":"2013","journal-title":"BMC Infect. Dis."},{"issue":"5305","key":"10.1016\/j.cellimm.2022.104554_b0640","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.275.5305.1481","article-title":"Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway","volume":"275","author":"Ott","year":"1997","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.cellimm.2022.104554_b0645","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1073\/pnas.95.7.3851","article-title":"Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS","volume":"95","author":"Zagury","year":"1998","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"12","key":"10.1016\/j.cellimm.2022.104554_b0650","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1128\/jvi.66.12.7159-7167.1992","article-title":"Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines","volume":"66","author":"Buonaguro","year":"1992","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.cellimm.2022.104554_b0655","doi-asserted-by":"crossref","first-page":"14883","DOI":"10.1074\/jbc.272.23.14883","article-title":"HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors","volume":"272","author":"Ambrosino","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.cellimm.2022.104554_b0660","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.4049\/jimmunol.180.11.7240","article-title":"Activation of NF-kappaB1 by OX40 contributes to antigen-driven T cell expansion and survival","volume":"180","author":"Song","year":"2008","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104554_b0665","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.chom.2008.02.002","article-title":"Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation","volume":"3","author":"Kwon","year":"2008","journal-title":"Cell Host Microbe"},{"issue":"8","key":"10.1016\/j.cellimm.2022.104554_b0670","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1093\/nar\/gkr1224","article-title":"Human immunodeficiency virus-1 Tat activates NF-kappaB via physical interaction with IkappaB-alpha and p65","volume":"40","author":"Fiume","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.cellimm.2022.104554_b0675","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.1128\/JVI.73.8.7080-7086.1999","article-title":"Human immunodeficiency virus type 1 tat protein activates transcription factor NF-kappaB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase","volume":"73","author":"Demarchi","year":"1999","journal-title":"PKR. J Virol."},{"issue":"4","key":"10.1016\/j.cellimm.2022.104554_b0680","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1128\/jvi.68.4.2677-2682.1994","article-title":"The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure","volume":"68","author":"Buonaguro","year":"1994","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.cellimm.2022.104554_b0685","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1182\/blood-2009-10-233585","article-title":"NFAT pulls the strings during CD4+ T helper cell effector functions","volume":"115","author":"Hermann-Kleiter","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2022.104554_b0690","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12879-016-1647-3","article-title":"Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort","volume":"16","author":"Nicoli","year":"2016","journal-title":"BMC Infect. Dis."},{"issue":"6","key":"10.1016\/j.cellimm.2022.104554_b0695","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179882","article-title":"HIV-Tat regulates macrophage gene expression in the context of neuroAIDS","volume":"12","author":"Carvallo","year":"2017","journal-title":"PLoS ONE"},{"issue":"20","key":"10.1016\/j.cellimm.2022.104554_b0700","doi-asserted-by":"crossref","first-page":"11601","DOI":"10.1073\/pnas.95.20.11601","article-title":"HIV-1 tat binds TAFII250 and represses TAFII250-dependent transcription of major histocompatibility class I genes","volume":"95","author":"Weissman","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5112","key":"10.1016\/j.cellimm.2022.104554_b0705","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.8493575","article-title":"Repression of MHC class I gene promoter activity by two-exon Tat of HIV","volume":"260","author":"Howcroft","year":"1993","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cellimm.2022.104554_b0710","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/1074-7613(95)90165-5","article-title":"HIV Tat represses transcription through Spl-Like elements in the basal promoter","volume":"3","author":"Kevin Howcroft","year":"1995","journal-title":"Immunity"},{"issue":"22","key":"10.1016\/j.cellimm.2022.104554_b0715","doi-asserted-by":"crossref","first-page":"12432","DOI":"10.1073\/pnas.211444798","article-title":"TAFII55 binding to TAFII250 inhibits its acetyltransferase activity","volume":"98","author":"Gegonne","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.cellimm.2022.104554_b0720","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.virol.2009.06.008","article-title":"Nef-mediated MHC class I down-regulation unmasks clonal differences in virus suppression by SIV-specific CD8(+) T cells independent of IFN-gamma and CD107a responses","volume":"391","author":"Minang","year":"2009","journal-title":"Virology"},{"issue":"14","key":"10.1016\/j.cellimm.2022.104554_b0725","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1089\/08892220152596623","article-title":"Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes","volume":"17","author":"Andrieu","year":"2001","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"8","key":"10.1016\/j.cellimm.2022.104554_b0730","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-020-0274-9","article-title":"CD8(+) T cells in HIV control, cure and prevention","volume":"20","author":"Collins","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.cellimm.2022.104554_b0735","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.4049\/jimmunol.1600967","article-title":"Low-level MHC class II expression leads to suboptimal Th cell response, increased autoaggression, and heightened cytokine inducibility","volume":"198","author":"Chen","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2022.104554_b0740","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fimmu.2014.00174","article-title":"How do CD4(+) T cells detect and eliminate tumor cells that either lack or express MHC class II molecules?","volume":"5","author":"Haabeth","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2022.104554_b0745","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fimmu.2013.00476","article-title":"CIITA and its dual roles in MHC gene transcription","volume":"4","author":"Devaiah","year":"2013","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104554_b0750","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1074-7613(00)80159-4","article-title":"Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC Class II genes in HIV infection","volume":"12","author":"Kanazawa","year":"2000","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.cellimm.2022.104554_b0755","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nri1960","article-title":"Dendritic-cell interactions with HIV: infection and viral dissemination","volume":"6","author":"Wu","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104554_b0760","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.2000.3972","article-title":"Reciprocal modulation of transcriptional activities between HIV-1 Tat and MHC class II transactivator CIITA","volume":"279","author":"Okamoto","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104554_b0765","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1128\/JVI.01759-12","article-title":"Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals","volume":"87","author":"Qin","year":"2013","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.cellimm.2022.104554_b0770","doi-asserted-by":"crossref","first-page":"F31","DOI":"10.1097\/QAD.0b013e328354b43f","article-title":"Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells","volume":"26","author":"Vollbrecht","year":"2012","journal-title":"AIDS."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104554_b0775","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/infdis\/jit469","article-title":"HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity","volume":"209","author":"Garg","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.cellimm.2022.104554_b0780","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/QAD.0000000000001083","article-title":"Expansion of myeloid-derived suppressor cells promotes differentiation of regulatory T cells in HIV-1+ individuals","volume":"30","author":"Wang","year":"2016","journal-title":"AIDS."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104554_b0785","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003993","article-title":"Immune suppression by neutrophils in HIV-1 infection: role of PD-L1\/PD-1 pathway","volume":"10","author":"Bowers","year":"2014","journal-title":"PLoS Pathog."},{"issue":"18","key":"10.1016\/j.cellimm.2022.104554_b0790","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1097\/QAD.0000000000000871","article-title":"In HIV-positive patients, myeloid-derived suppressor cells induce T-cell anergy by suppressing CD3zeta expression through ELF-1 inhibition","volume":"29","author":"Tumino","year":"2015","journal-title":"AIDS."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104554_b0795","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/QAI.0000000000001471","article-title":"Myeloid-derived suppressor cells associated with disease progression in primary HIV infection: PD-L1 blockade attenuates inhibition","volume":"76","author":"Zhang","year":"2017","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.cellimm.2022.104554_b0800","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3389\/fimmu.2018.00811","article-title":"Treatment intensification in HIV-infected patients is associated with reduced frequencies of regulatory T cells","volume":"9","author":"Grutzner","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2022.104554_b0805","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3389\/fimmu.2019.01886","article-title":"Myeloid derived suppressor cells expansion persists after early ART and may affect CD4 T cell recovery","volume":"10","author":"Agrati","year":"2019","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.cellimm.2022.104554_b0810","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1097\/QAD.0000000000002700","article-title":"Long noncoding RNA HOTAIRM1 promotes myeloid-derived suppressor cell expansion and suppressive functions through up-regulating HOXA1 expression during latent HIV infection","volume":"34","author":"Zhang","year":"2020","journal-title":"AIDS."},{"key":"10.1016\/j.cellimm.2022.104554_b0815","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3389\/fimmu.2017.00580","article-title":"Pathophysiology of CD4+ T-Cell Depletion in HIV-1 and HIV-2 Infections","volume":"8","author":"Vidya Vijayan","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2022.104554_b0820","article-title":"A Matter of life or death: productively infected and bystander CD4 T cells in early HIV infection","volume":"11","author":"Cao","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104554_b0825","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.chom.2016.02.012","article-title":"Dissecting How CD4 T Cells Are Lost During HIV Infection","volume":"19","author":"Doitsh","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cellimm.2022.104554_b0830","unstructured":"!!! INVALID CITATION !!! { }."},{"issue":"16","key":"10.1016\/j.cellimm.2022.104554_b0835","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1089\/aid.1996.12.1529","article-title":"Effect of HIV type 1 Tat protein on butyric acid-induced differentiation in a hematopoietic progenitor cell line","volume":"12","author":"Mondal","year":"1996","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"13","key":"10.1016\/j.cellimm.2022.104554_b0840","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1089\/088922202760265597","article-title":"Suppression of clonogenic potential of human bone marrow mesenchymal stem cells by HIV type 1: putative role of HIV type 1 tat protein and inflammatory cytokines","volume":"18","author":"Wang","year":"2002","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.cellimm.2022.104554_b0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2019.197756","article-title":"HIV-1 Tat protein inhibits the hematopoietic support function of human bone marrow mesenchymal stem cells","volume":"273","author":"Yuan","year":"2019","journal-title":"Virus Res."},{"issue":"12","key":"10.1016\/j.cellimm.2022.104554_b0850","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1182\/blood.V80.12.3036.3036","article-title":"tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression","volume":"80","author":"Zauli","year":"1992","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cellimm.2022.104554_b0855","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/ajcp\/92.5.589","article-title":"Bone marrow examination in patients with AIDS and AIDS-related complex (ARC). Morphologic and in situ hybridization studies","volume":"92","author":"Sun","year":"1989","journal-title":"Am. J. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.cellimm.2022.104554_b0860","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/infdis\/jir884","article-title":"HIV-1 DNA is detected in bone marrow populations containing CD4+ T cells but is not found in purified CD34+ hematopoietic progenitor cells in most patients on antiretroviral therapy","volume":"205","author":"Durand","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cellimm.2022.104554_b0865","first-page":"e5","article-title":"Bone marrow CD34+ progenitor cells may harbour HIV-DNA even in successfully treated patients","author":"Bordoni","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104554_b0870","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/QAD.0b013e3282f2589b","article-title":"The role of the thymus in HIV infection: a 10 year perspective","volume":"22","author":"Ho Tsong Fang","year":"2008","journal-title":"AIDS"},{"issue":"9","key":"10.1016\/j.cellimm.2022.104554_b0875","first-page":"837","article-title":"Thymus biopsy in children with acquired immunodeficiency syndrome","volume":"110","author":"Joshi","year":"1986","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104554_b0880","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1542\/peds.89.2.297","article-title":"Thymic abnormalities in fetuses aborted from human immunodeficiency virus type 1 seropositive women","volume":"89","author":"Papiernik","year":"1992","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.cellimm.2022.104554_b0885","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1172\/JCI2834","article-title":"High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection","volume":"101","author":"McCune","year":"1998","journal-title":"J Clin Invest."},{"issue":"17","key":"10.1016\/j.cellimm.2022.104554_b0890","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1089\/088922201753342040","article-title":"Thymopoiesis in HIV-infected adults after highly active antiretroviral therapy","volume":"17","author":"Markert","year":"2001","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"22","key":"10.1016\/j.cellimm.2022.104554_b0895","doi-asserted-by":"crossref","first-page":"12685","DOI":"10.1128\/JVI.01131-07","article-title":"Efficient thymopoiesis contributes to the maintenance of peripheral CD4 T cells during chronic human immunodeficiency virus type 2 infection","volume":"81","author":"Gautier","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.cellimm.2022.104554_b0900","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fimmu.2019.00025","article-title":"Thymic function as a predictor of immune recovery in chronically HIV-infected patients initiating antiretroviral therapy","volume":"10","author":"Rb-Silva","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104554_b0905","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/QAD.0000000000000063","article-title":"Antiretroviral therapy increases thymic output in children with HIV","volume":"28","author":"Sandgaard","year":"2014","journal-title":"AIDS."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104554_b0910","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1203\/00006450-200208000-00012","article-title":"Production of new T cells by thymus in children: effect of HIV infection and antiretroviral therapy","volume":"52","author":"Correa","year":"2002","journal-title":"Pediatr. Res."},{"issue":"7","key":"10.1016\/j.cellimm.2022.104554_b0915","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1182\/blood.V86.7.2481.2481","article-title":"Mitochondrial dysfunctions in circulating T lymphocytes from human immunodeficiency virus-1 carriers","volume":"86","author":"Macho","year":"1995","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cellimm.2022.104554_b0920","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/423176","article-title":"Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals","volume":"39","author":"Miro","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.cellimm.2022.104554_b0925","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa012035","article-title":"Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients","volume":"346","author":"Cote","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.cellimm.2022.104554_b0930","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nm0595-417","article-title":"Mitochondrial toxicity of antiviral drugs","volume":"1","author":"Lewis","year":"1995","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104554_b0935","first-page":"181","article-title":"Extensive investigations of mitochondrial DNA genome in treated HIV-infected subjects: beyond mitochondrial DNA depletion","volume":"39","author":"McComsey","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104554_b0940","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3851\/IMP1530","article-title":"Proteomic analysis identifies prohibitin down-regulation as a crucial event in the mitochondrial damage observed in HIV-infected patients","volume":"15","author":"Ciccosanti","year":"2010","journal-title":"Antivir Ther."},{"issue":"11","key":"10.1016\/j.cellimm.2022.104554_b0945","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/sj.cdd.4401668","article-title":"Mitochondrial complex I activity is impaired during HIV-1-induced T-cell apoptosis","volume":"12","author":"Ladha","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cellimm.2022.104554_b0950","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12977-015-0203-3","article-title":"Intracellular expression of Tat alters mitochondrial functions in T cells: a potential mechanism to understand mitochondrial damage during HIV-1 replication","volume":"12","author":"Rodriguez-Mora","year":"2015","journal-title":"Retrovirology."},{"issue":"11","key":"10.1016\/j.cellimm.2022.104554_b0955","doi-asserted-by":"crossref","first-page":"7626","DOI":"10.1074\/jbc.M112.408294","article-title":"The presence of HIV-1 Tat protein second exon delays fas protein-mediated apoptosis in CD4+ T lymphocytes: a potential mechanism for persistent viral production","volume":"288","author":"Lopez-Huertas","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.cellimm.2022.104554_b0960","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.1093\/emboj\/cdf683","article-title":"HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim","volume":"21","author":"Chen","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.cellimm.2022.104554_b0965","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-4690-2-5","article-title":"HIV-1 Tat protein enhances microtubule polymerization","volume":"2","author":"de Mareuil","year":"2005","journal-title":"Retrovirology."},{"issue":"46","key":"10.1016\/j.cellimm.2022.104554_b0970","doi-asserted-by":"crossref","first-page":"48197","DOI":"10.1074\/jbc.M406195200","article-title":"The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis","volume":"279","author":"Campbell","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"Suppl 1","key":"10.1016\/j.cellimm.2022.104554_b0975","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1002\/pmic.200500437","article-title":"Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression","volume":"6","author":"Coiras","year":"2006","journal-title":"Proteomics"},{"issue":"3","key":"10.1016\/j.cellimm.2022.104554_b0980","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/jcp.20252","article-title":"HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: a potential molecular mechanism to escape TRAIL cytotoxicity","volume":"203","author":"Gibellini","year":"2005","journal-title":"J. Cell. Physiol."},{"issue":"11","key":"10.1016\/j.cellimm.2022.104554_b0985","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1002\/eji.1830271110","article-title":"Extracellular HIV-1 Tat protein activates phosphatidylinositol 3- and Akt\/PKB kinases in CD4+ T lymphoblastoid Jurkat cells","volume":"27","author":"Borgatti","year":"1997","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.cellimm.2022.104554_b0990","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00005072-199806000-00004","article-title":"Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement","volume":"57","author":"Jones","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104554_b0995","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/088922204322996536","article-title":"Zn2+ binding to cysteine-rich domain of extracellular human immunodeficiency virus type 1 Tat protein is associated with Tat protein-induced apoptosis","volume":"20","author":"Misumi","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"2","key":"10.1016\/j.cellimm.2022.104554_b1000","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.taap.2009.06.020","article-title":"PDGF-mediated protection of SH-SY5Y cells against Tat toxin involves regulation of extracellular glutamate and intracellular calcium","volume":"240","author":"Zhu","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"7","key":"10.1016\/j.cellimm.2022.104554_b1005","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.4049\/jimmunol.174.7.4333","article-title":"HIV-1 transactivator of transcription protein induces mitochondrial hyperpolarization and synaptic stress leading to apoptosis","volume":"174","author":"Perry","year":"2005","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104554_b1010","doi-asserted-by":"crossref","first-page":"869","DOI":"10.4049\/jimmunol.178.2.869","article-title":"HIV-1 trans activator of transcription protein elicits mitochondrial hyperpolarization and respiratory deficit, with dysregulation of complex IV and nicotinamide adenine dinucleotide homeostasis in cortical neurons","volume":"178","author":"Norman","year":"2007","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.cellimm.2022.104554_b1015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029436","article-title":"The HIV-1 transactivator factor (Tat) induces enterocyte apoptosis through a redox-mediated mechanism","volume":"6","author":"Buccigrossi","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellimm.2022.104554_b1020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1742-4690-5-62","article-title":"Modulation of microtubule assembly by the HIV-1 Tat protein is strongly dependent on zinc binding to Tat","volume":"5","author":"Egele","year":"2008","journal-title":"Retrovirology."},{"key":"10.1016\/j.cellimm.2022.104554_b1025","doi-asserted-by":"crossref","unstructured":"Hohmann T, Dehghani F. The Cytoskeleton-A Complex Interacting Meshwork. Cells. 2019;8(4).","DOI":"10.3390\/cells8040362"},{"issue":"5957","key":"10.1016\/j.cellimm.2022.104554_b1030","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1175862","article-title":"Actin, a central player in cell shape and movement","volume":"326","author":"Pollard","year":"2009","journal-title":"Science"},{"issue":"7280","key":"10.1016\/j.cellimm.2022.104554_b1035","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nature08908","article-title":"Cell mechanics and the cytoskeleton","volume":"463","author":"Fletcher","year":"2010","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cellimm.2022.104554_b1040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/v3040293","article-title":"How HIV takes advantage of the cytoskeleton in entry and replication","volume":"3","author":"Stolp","year":"2011","journal-title":"Viruses."},{"issue":"9","key":"10.1016\/j.cellimm.2022.104554_b1045","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.bpj.2009.08.016","article-title":"Retroviral assembly and budding occur through an actin-driven mechanism","volume":"97","author":"Gladnikoff","year":"2009","journal-title":"Biophys. J."},{"issue":"Suppl 1","key":"10.1016\/j.cellimm.2022.104554_b1050","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/sj.cdd.4401582","article-title":"Human immunodeficiency virus (HIV)-1 proteins and cytoskeleton: partners in viral life and host cell death","volume":"12","author":"Matarrese","year":"2005","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104554_b1055","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1083\/jcb.200203150","article-title":"Visualization of the intracellular behavior of HIV in living cells","volume":"159","author":"McDonald","year":"2002","journal-title":"J. Cell Biol."},{"issue":"10","key":"10.1016\/j.cellimm.2022.104554_b1060","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1182\/blood.V86.10.3823.bloodjournal86103823","article-title":"The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells","volume":"86","author":"Zauli","year":"1995","journal-title":"Blood"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874922000788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874922000788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T23:09:18Z","timestamp":1757804958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874922000788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":212,"alternative-id":["S0008874922000788"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2022.104554","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T-cell evasion and invasion during HIV-1 infection: The role of HIV-1 Tat protein","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2022.104554","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104554"}}